Fibroblast Growth Factor-2 facilitates the growth and chemo-resistance of leukemia cells in the bone marrow by modulating osteoblast functions-Reference-Cited by-同舟云学术

Fibroblast Growth Factor-2 facilitates the growth and chemo-resistance of leukemia cells in the bone marrow by modulating osteoblast functions

Published:2016-08-02 Issue:1 Volume:6 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Sugimoto Keiki,Miyata Yasuhiko,Nakayama Takayuki,Saito Shigeki,Suzuki Ritsuro,Hayakawa Fumihiko,Nishiwaki Satoshi,Mizuno Hiroki,Takeshita Kyosuke,Kato Hidefumi,Ueda Ryuzo,Takami Akiyoshi,Naoe Tomoki

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep30779.pdf

Reference51 articles.

1. Weissman, I. L. Stem cells: units of development, units of regeneration and units in evolution. Cell 100, 157–168 (2000).

2. Morrison, S. J. & Scadden, D. T. The bone marrow niche for haematopoietic stem cells. Nature 505, 327–334, doi: 10.1038/nature12984 (2014).

3. Asada, N. & Katayama, Y. Regulation of hematopoiesis in endosteal microenvironments. International journal of hematology 99, 679–684, doi: 10.1007/s12185-014-1583-1 (2014).

4. Boulais, P. E. & Frenette, P. S. Making sense of hematopoietic stem cell niches. Blood 125, 2621–2629, doi: 10.1182/blood-2014-09-570192 (2015).

5. Schepers, K., Campbell, T. B. & Passegue, E. Normal and leukemic stem cell niches: insights and therapeutic opportunities. Cell stem cell 16, 254–267, doi: 10.1016/j.stem.2015.02.014 (2015).

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Excessive osteoclast activation by osteoblast paracrine factor RANKL is a major cause of the abnormal long bone phenotype in Apert syndrome model mice;Journal of Cellular Physiology;2022-01-20

2. Anlotinib: A Novel Targeted Drug for Bone and Soft Tissue Sarcoma;Frontiers in Oncology;2021-05-20

3. Precocious clonal hematopoiesis in Down syndrome is accompanied by immune dysregulation;Blood Advances;2021-03-31

4. Bioinformatics Investigation and Contribution of Other Chromosomes Besides Chromosome 21 in the Risk of Down Syndrome Development;Basic and Clinical Neuroscience Journal;2021-01-01

Identification of Chemoresistance-Associated Key Genes and Pathways in High-Grade Serous Ovarian Cancer by Bioinformatics Analyses

;Cancer Management and Research;2020-06